IMVT IMMUNOVANT
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · before market open
What 17 analyst firms say about IMMUNOVANT: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
16 rated views · 17 analyst/firm records · 17 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8047
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8045
Recent analyst activity · last 90 days
Our tracked history has 7 reports on IMVT from 6 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: HC Wainwright raised its target from $40.00 (set 21 May 2026) to $41.00 on 24 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Jason Gerberry | Buy | 21 May 2026 | 43.00 USD |
| Bernstein | Jeffrey Walch | Hold | 29 Jul 2026 | 37.00 USD |
| Cantor Fitzgerald | Prakhar Agrawal | Buy | 25 Aug 2026 | — |
| Citigroup | Samantha Semenkow | Buy | 24 Sep 2026 | 61.00 USD |
| Goldman Sachs | Corinne Johnson | Hold | 15 Apr 2026 | Conflicting reports · excluded |
| Guggenheim | Yastin Suneja | Buy | 26 May 2026 | 62.00 USD |
| H.C. Wainwright | Douglas Tsao | Buy | 24 Sep 2026 | 41.00 USD |
| Jefferies | Dennis Ding | Hold | 21 May 2026 | 35.00 USD |
| JPMorgan | Brian Cheng | Buy | 4 Aug 2026 | 50.00 USD |
| Leerink Partners | Thomas J Smith | Buy | 2 Apr 2026 | 59.00 USD |
| Lifesci Capital | Sam Slutsky | Buy | 9 Jul 2026 | 53.00 USD |
| Truist | Danielle Brill | Hold | 22 May 2026 | 30.00 USD |
| UBS | Ashwani Verma | Hold | 24 Aug 2026 | 40.00 USD |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| Wells Fargo | Derek C Archila | Buy | 26 Aug 2026 | 45.00 USD |
| Wolfe Research | Andy Chen | Buy | 6 Jan 2026 | Conflicting reports · excluded |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 35.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:47 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.